FHAM
BIO icon

Folger Hill Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Folger Hill Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,840
Closed -$4.15M – 272
2017
Q1 		$4.15M Buy
20,840
+7,147
+52% +$1.38M 0.33% 101
2016
Q4 		$2.5M Buy
+13,693
New +$2.33M 0.23% 126

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Folger Hill Asset Management's BIO Position: Q2 2017 in Review

Folger Hill Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2017, closing a stake of 20,840 shares — an estimated $4.15M sold.

Folger Hill Asset Management first reported a position in BIO in Q4 2016 and held it in 2 quarters. The position peaked at $4.15M in Q1 2017. 276 funds tracked by Wall St. Rank hold BIO as of Q2 2017.

  • Folger Hill Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 20,840 Bio-Rad Laboratories Class A shares in Q2 2017, an estimated $4.15M.
  • Folger Hill Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 2 quarters.
  • Folger Hill Asset Management's Bio-Rad Laboratories Class A position peaked at $4.15M in Q1 2017.
  • 276 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2017.

Based on Folger Hill Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.